Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed2

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

LeukemiaLeukemia, Lymphocytic, Chronic, B-CellMarginal Zone Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, FollicularMarginal Zone Lymphoma
Similarity Score11%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphoma, FollicularLeukemia, Lymphocytic, Chronic, B-Cell

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, FollicularLymphoma, Mantle-Cell
Similarity Score11%

Farhad Ravandi, MD

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

LeukemiaLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score8%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLeukemia

Worked with same sponsors:

M.D. Anderson Cancer Center
Similarity Score8%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Leukemia

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Leukemia

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Gary Schiller, MD

University of California, Los Angeles

Related
3 trials

Shared therapeutic areas:

Leukemia
Similarity Score4%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Leukemia
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00880815Phase 1PrincipalInvestigator

Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant

CD20 PositiveChronic Lymphocytic LeukemiaFollicular Lymphoma+4 more
Completed
NCT00002838Phase 1/2StudyChair

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia

Leukemia
Completed

All 2 trials loaded